Medpace Holdings Inc. logo

Medpace Holdings Inc. (MEDP)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
618. 47
-10.13
-1.6115%
After Hours
$
640. 00
+21.53 +3.4812%
17.55B Market Cap
35.12 P/E Ratio
- Div Yield
284,790 Volume
8.64 Eps
$ 628.6
Previous Close
Add Transaction
Day Range
610.21 632.33
Year Range
373 677.9
Want to track MEDP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why the Market Dipped But Medpace (MEDP) Gained Today

Why the Market Dipped But Medpace (MEDP) Gained Today

Medpace (MEDP) closed at $616.45 in the latest trading session, marking a +1.32% move from the prior day.

Zacks | 9 months ago
Medpace (MEDP) Stock Dips While Market Gains: Key Facts

Medpace (MEDP) Stock Dips While Market Gains: Key Facts

Medpace (MEDP) closed the most recent trading day at $600.02, moving 2.13% from the previous trading session.

Zacks | 9 months ago
Why Medpace (MEDP) Dipped More Than Broader Market Today

Why Medpace (MEDP) Dipped More Than Broader Market Today

In the most recent trading session, Medpace (MEDP) closed at $561.65, indicating a -1.27% shift from the previous trading day.

Zacks | 9 months ago
Medpace (MEDP) Outperforms Broader Market: What You Need to Know

Medpace (MEDP) Outperforms Broader Market: What You Need to Know

In the latest trading session, Medpace (MEDP) closed at $568.36, marking a +1.45% move from the previous day.

Zacks | 10 months ago
Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 11 months ago
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?

Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?

Here is how Medpace (MEDP) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

Zacks | 11 months ago
Medpace (MEDP) Upgraded to Strong Buy: What Does It Mean for the Stock?

Medpace (MEDP) Upgraded to Strong Buy: What Does It Mean for the Stock?

Medpace (MEDP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 11 months ago
Medpace (MEDP) Beats Q3 Earnings and Revenue Estimates

Medpace (MEDP) Beats Q3 Earnings and Revenue Estimates

Medpace (MEDP) came out with quarterly earnings of $3.86 per share, beating the Zacks Consensus Estimate of $3.5 per share. This compares to earnings of $3.01 per share a year ago.

Zacks | 11 months ago
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts

Medpace (MEDP) Rises As Market Takes a Dip: Key Facts

Medpace (MEDP) concluded the recent trading session at $521.21, signifying a +1.34% move from its prior day's close.

Zacks | 0 year ago
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?

Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?

Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?

Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?

Here is how Medpace (MEDP) and Black Diamond (BDTX) have performed compared to their sector so far this year.

Zacks | 1 year ago
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors

Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors

Medpace (MEDP) closed at $536.17 in the latest trading session, marking a -1.42% move from the prior day.

Zacks | 1 year ago
Loading...
Load More